UPDATED Aug 22, 2025
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
TMO | US$499.99 | 3.4% | -17.5% | US$182.7b | US$552.38 | PE28.7x | E9.6% | 0.3% | ||
DHR | US$211.80 | 3.9% | -21.4% | US$146.0b | US$245.95 | PE44.4x | E15.5% | 0.6% | ||
MRK | US$87.37 | 1.5% | -25.1% | US$215.0b | US$100.41 | PE13.3x | E8.3% | 3.7% | ||
ABBV | US$210.60 | 0.5% | 6.6% | US$370.1b | US$214.77 | PE99.9x | E27.6% | 3.1% | ||
LLY | US$711.68 | 0.3% | -25.3% | US$637.2b | US$887.60 | PE46.3x | E21.2% | 0.8% | ||
A | US$121.63 | 3.8% | -13.7% | US$33.3b | US$137.57 | PE29.6x | E11.0% | 0.8% | ||
IQV | US$191.15 | 3.1% | -23.2% | US$31.5b | US$215.05 | PE26.3x | E13.2% | 0% | ||
MTD | US$1,321.45 | 3.4% | -8.0% | US$26.3b | US$1,294.55 | PE32.8x | E7.6% | n/a | ||
JNJ | US$179.29 | 0.2% | 9.2% | US$430.9b | US$175.57 | PE19.1x | E-0.5% | 2.9% | ||
PFE | US$25.88 | 0.5% | -10.4% | US$146.3b | US$28.77 | PE13.7x | E1.1% | 6.6% | ||
WAT | US$302.19 | 4.0% | -11.7% | US$17.3b | US$350.24 | PE27.2x | E10.9% | n/a | ||
TEM | US$80.52 | 5.0% | 24.0% | US$13.3b | US$71.00 | PS14.7x | E13.4% | n/a | ||
RVTY | US$94.15 | 5.0% | -22.4% | US$10.4b | US$116.81 | PE39.2x | E24.3% | 0.3% | ||
NTRA | US$165.60 | 2.3% | 35.0% | US$22.2b | US$197.80 | PS11.6x | E66.9% | n/a | ||
BIO | US$303.82 | 6.6% | -3.5% | US$7.5b | US$326.50 | PE25.8x | E-2.3% | n/a | ||
TECH | US$57.09 | 5.7% | -21.0% | US$8.5b | US$65.31 | PE121.9x | E23.1% | 0.6% | ||
AVTR | US$13.27 | 5.7% | -48.3% | US$8.6b | US$14.12 | PE13.2x | E-8.4% | n/a | ||
ZTS | US$156.62 | 0.6% | -13.4% | US$69.0b | US$190.29 | PE26.6x | E7.3% | 1.3% | ||
ILMN | US$101.80 | 2.5% | -22.5% | US$15.3b | US$112.05 | PE12.4x | E-3.9% | n/a | ||
WST | US$247.85 | 2.2% | -18.1% | US$17.4b | US$316.36 | PE36.5x | E11.5% | 0.4% | ||
CRL | US$161.84 | 4.7% | -21.2% | US$7.6b | US$166.67 | PS2x | E37.0% | n/a | ||
MRNA | US$27.12 | 3.4% | -67.1% | US$10.2b | US$45.45 | PS3.4x | E37.3% | n/a | ||
CAI | US$39.30 | 3.1% | n/a | US$10.7b | US$39.38 | PS20.7x | E80.2% | n/a | ||
MEDP | US$463.64 | 2.3% | 18.6% | US$12.7b | US$410.27 | PE31.1x | E8.6% | n/a |